← Back to your selection

The National Cancer Institute

Activity from announced rounds

Activity in this selectionggv-capital-8202fb6d
Rounds participated in
1
Confirmed lead rounds
—
1 roles undisclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$10M
1 disclosed · full round size, not this investor’s share

By stage

Series A1

By primary sector

Biotech1

By country

United States1

Rounds

1 in this selection
Vivere Oncotherapies

Develops cancer therapies that activate the immune system to detect and destroy cancer cells in t...

$10MSeries A
Role not disclosed